Praxis Precision Medicines (PRAX) Current Leases (2019 - 2026)

Praxis Precision Medicines' Current Leases history runs 8 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Current Leases rose 34.62% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 34.62% YoY), while the FY2025 annual figure was $110000.0, down 91.26% from the prior year.
• Current Leases for Q1 2026 stood at $1.4 million, up from $110000.0 in the prior quarter.
• The five-year high for Current Leases was $1.4 million in Q1 2026, with the low at $110000.0 in Q4 2025.
• The 5-year median for Current Leases is $1.1 million (2023), against an average of $994705.9.
• The sharpest annual moves came in 2022 and 2025: Current Leases soared 77.34% in 2022, then sank 91.26% in 2025.
• Praxis Precision Medicines' Current Leases stood at $1.0 million in 2022, then advanced by 12.04% to $1.1 million in 2023, then grew by 11.81% to $1.3 million in 2024, then tumbled by 91.26% to $110000.0 in 2025, then surged by 1204.55% to $1.4 million in 2026.
• Business Quant data shows PRAX's Current Leases at $1.4 million in Q1 2026, $110000.0 in Q4 2025, and $436000.0 in Q3 2025.